The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2
Thierry Christophe(Galapagos (Belgium)), Cláes Dahlgren(Centre for Inflammation Research), Christophe Dugave(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Anna Karlsson(Chalmers University of Technology), F. Boulay(Centre National de la Recherche Scientifique), Marie‐Josèphe Rabiet(Centre National de la Recherche Scientifique)
Cited by 205
Related Papers
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
|Pharmacological Reviews|2009|770
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils.
|The Journal of Immunology|1995|314
Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes
|Infection and Immunity|1983|244